It’s not known whether Cosentyx (secukinumab) is safe to receive while pregnant or breastfeeding. Certain factors may ...
The following is a summary of “Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network,” published in the ...
At the recent SEC meeting for analgesics and rheumatology held on February 25, 2025, the expert panel reviewed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results